Latest filing published 30 Jan 2025 for Dexcom Inc, €99k.
Filing timeline
BuySaleInsider track record
Matthew Vincent Dolan: trading record in brief
Fifteen sales out of 27 filings: the record of Matthew Vincent Dolan at Dexcom Inc, a Nasdaq company where the listed title is SVP Corporate Strategy-Develop. The sales total EUR 3,712,364, with a median of EUR 223,865, and no purchase appears. The largest are EUR 825,054 (March 12, 2024), EUR 619,597 (March 13, 2023) and EUR 382,894 (March 15, 2022), one a year, each time in mid-March.
The filings were published from March 10, 2022 to January 30, 2025: 9 in 2022, 9 in 2023, 7 in 2024 and 2 in 2025. There are 4 share grants and 8 filings of another kind, with no option exercise. None falls in the last twelve months, since the latest filing is from January 30, 2025.
The median publication delay is 2 days. Within 30 days of colleagues at Dexcom Inc, Dolan has 13, 12 and 11 own market trades, in that order. All in the same direction. The colleagues, in the same order: Jereme M. Sylvain, Kevin R. Sayer and Sadie Stern.
Companies and markets linked to Matthew Vincent Dolan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,183 shares@ US$86.912.0% of flowCommon StockSEC:0001093557-25-000018:1
- 3,048 shares0Common StockSEC:0001093557-25-000018:0
- 2,423 shares@ US$126.5811.8% of flowCommon StockSEC:0001093557-24-000083:0
- 1,990 shares@ US$137.8110.8% of flowCommon StockSEC:0001093557-24-000064:0
- 1,314 shares@ US$130.773.2% of flowCommon StockSEC:0001093557-24-000056:1
- 1,003 shares@ US$131.392.4% of flowCommon StockSEC:0001093557-24-000056:2
- 1,886 shares@ US$129.18429.3% of flowCommon StockSEC:0001093557-24-000056:0
- 6,710 shares@ US$134.410734.4% of flowCommon StockSEC:0001093557-24-000049:0
- 21,711 shares0Common StockSEC:0001093557-24-000035:0
- 56 shares@ US$102.320.2% of flowCommon StockSEC:0001093557-23-000197:0
- 2,303 shares@ US$115.0010.4% of flowCommon StockSEC:0001093557-23-000089:0
- 1,650 shares@ US$111.403.5% of flowCommon StockSEC:0001093557-23-000077:1
- 2,397 shares@ US$111.405.1% of flowCommon StockSEC:0001093557-23-000077:2
- 787 shares@ US$111.401.7% of flowCommon StockSEC:0001093557-23-000077:3
- 6,229 shares@ US$106.2712.5% of flowCommon StockSEC:0001093557-23-000077:4
- 1,370 shares@ US$111.3996.0% of flowCommon StockSEC:0001093557-23-000077:0
- 21,769 shares@ US$0.0010.0% of flowCommon StockSEC:0001093557-23-000057:0
- 226 shares@ US$114.401.0% of flowCommon StockSEC:0001093557-23-000033:0
- 5 shares@ US$81.630.0% of flowCommon StockSEC:0001093557-22-000155:0
- 686 shares@ US$425.005.4% of flowCommon StockSEC:0001093557-22-000065:1
- 484 shares@ US$450.004.0% of flowCommon StockSEC:0001093557-22-000065:2
- 1,016 shares@ US$412.4116.0% of flowCommon StockSEC:0001093557-22-000065:0
- 393 shares@ US$406.062.9% of flowCommon StockSEC:0001093557-22-000047:1
- 192 shares@ US$406.061.4% of flowCommon StockSEC:0001093557-22-000047:2
- 489 shares@ US$406.063.7% of flowCommon StockSEC:0001093557-22-000047:3
25 of 27 declarations
